- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Sa | Procaps Group, S.A.: Procaps Receives Nasdaq Listing Determination; To Request Hearing and Further Stay Pending Hearing | 151 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Colombia, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), announced today that, on November 13, 2024, the Company received... ► Artikel lesen | |
| Fr | Procaps Group, S.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 01.11. | Procaps Group, S.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 10.10. | Procaps Group, S.A.: Procaps Issues Shareholder Letter Update | 79 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Colombia, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services... ► Artikel lesen | |
| 08.10. | Procaps Group, S.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 18.09. | Procaps secures forbearance agreements and shareholder funds | 7 | Investing.com | ||
| PROCAPS GROUP Aktie jetzt für 0€ handeln | |||||
| 18.09. | Procaps sichert Stillhalteabkommen und Aktionärsgelder | 3 | Investing.com Deutsch | ||
| 18.09. | Procaps Group, S.A. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 18.09. | Procaps Group, S.A.: Procaps Issues Shareholder Letter Update | 233 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Colombia, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services... ► Artikel lesen | |
| 03.09. | Procaps Group, S.A. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 03.09. | Procaps Group, S.A.: Procaps Issues Shareholder Letter | 145 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Colombia, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical conglomerate... ► Artikel lesen | |
| 26.08. | Procaps Group, S.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 10.07. | Procaps Group, S.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 28.06. | Procaps Group Appoints Jose Minski To Succeed Ruben Minski As Executive Chairman | - | RTTNews | ||
| 28.06. | Procaps says exec chair Ruben Minski resigns | 1 | Seeking Alpha | ||
| 28.06. | Procaps Group, S.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 26.12.23 | Procaps Group Reports Third Quarter 2023 Results | 301 | Business Wire | MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated international healthcare and pharmaceutical services company... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 3,988 | -0,99 % | Aurora Cannabis Inc (3): Aurora Cannabis releases new recreational products | ||
| CANOPY GROWTH | 3,595 | +0,84 % | Jetzt wird es brenzlig: Kurse von Tilray, Canopy & Co. brechen massiv ein. So heftig könnte es werden | © Foto: Piyapong Thongdumhyu - 123rf StockfotoRund um die US-Wahl fielen weitere Entscheidungen. Während der Cannabis-Sektor die Wahl Trumps zum nächsten US-Präsidenten noch nicht so ganz einordnen... ► Artikel lesen | |
| TILRAY BRANDS | 1,234 | +0,37 % | Prediction: Tilray Brands Won't Be a Cannabis Company in 5 Years | ||
| TEVA | 16,100 | -0,62 % | Teva Pharmaceutical: Teva Takes on Antimicrobial Resistance: What You Need to Know | NORTHAMPTON, MA / ACCESSWIRE / November 20, 2024 / Antimicrobial resistance (AMR) happens when bacteria no longer respond to antibiotics, making infections harder to treat and increasing the risk and... ► Artikel lesen | |
| VERTEX PHARMACEUTICALS | 425,35 | -0,65 % | VERTEX - Wie kurz sind die Beine politischer Börsen? | ||
| ARZNEIWERK AG VIDA | 0,710 | +4,41 % | PTA-AFR: Arzneiwerk AG VIDA: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114-117 WpHG | DJ PTA-AFR: Arzneiwerk AG VIDA: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114-117 WpHG
Vorabbekanntmachung Finanzberichte gemäß §§ 114-117 WpHG
Berlin (pta/20.08.2024/15:00)... ► Artikel lesen | |
| CRONOS GROUP | 1,870 | -1,73 % | Cronos Group Inc. (CRON): A Bull Case Theory | ||
| VIATRIS | 12,330 | -1,08 % | Viatris Inc. Q3 Profit Decreases, But Beats Estimates | WASHINGTON (dpa-AFX) - Viatris Inc. (VTRS) released a profit for third quarter that decreased from the same period last year but beat the Street estimates.The company's earnings came in at $94.8... ► Artikel lesen | |
| INCYTE | 66,58 | 0,00 % | Aktie von Incyte an der Börse auf der Verliererseite: Börsenkurs fällt deutlich (62,00 €) | Keinen Grund zur Freude haben Anleger, die in den Anteilsschein von Incyte investiert haben: Der Kurs des Wertpapiers sackt kräftig ab. Zu den auffälligsten Werten im US-amerikanischen Wertpapierhandel... ► Artikel lesen | |
| BAUSCH HEALTH | 7,869 | +1,20 % | Bausch Health Companies Inc.: Bausch Health and Salix to Present at the American Association for the Study of Liver Disease the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis | Next generation product may increase gastrointestinal luminal concentration while limiting system exposure LAVAL, QC / ACCESSWIRE / November 18, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC)... ► Artikel lesen | |
| CRESCO LABS | 1,186 | +4,96 % | Cresco Labs Demonstrates Success of Cash Flow Focused Strategy with Third Quarter 2024 Financial Results | Record quarterly operating cash flow of $49 million and year to date operating cashflow of $103 million, an increase of 66% from the prior year period
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF)... ► Artikel lesen | |
| IONIS PHARMACEUTICALS | 31,690 | 0,00 % | Ionis Pharmaceuticals (NASDAQ:IONS) Hits New 12-Month Low on Insider Selling | ||
| ALNYLAM PHARMACEUTICALS | 234,40 | -0,72 % | Alnylam Presents New Phase 1 Results For Next-Gen RNAi Therapy Nucresiran In ATTR Amyloidosis | WASHINGTON (dpa-AFX) - Alnylam Pharmaceuticals Inc. (ALNY) has shared new findings from its Phase 1 study of nucresiran (previously known as ALN-TTRsc04), a next-generation RNAi therapy being... ► Artikel lesen | |
| NEKTAR THERAPEUTICS | 0,977 | +2,41 % | Nektar Therapeutics Presents First Preclinical Data from Novel CSF-1 Program, NKTR-422, at 2024 American College of Rheumatology (ACR) Convergence | - NKTR-422 demonstrated inflammation resolution and tissue repair in multiple preclinical models of chronic inflammatory conditions -
SAN FRANCISCO, Nov. 18,... ► Artikel lesen | |
| ORAMED PHARMACEUTICALS | 2,098 | -2,42 % | Oramed Pharmaceuticals Inc.: Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt | NEW YORK, Oct. 7, 2024 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ("Oramed"), a clinical-stage pharmaceutical company focused on the development of oral drug delivery... ► Artikel lesen |
PROCAPS GROUP SA gehört der Branche Pharma an. Die relative Kursveränderung beträgt aktuell +13,38 % bei einem Aktienkurs von 0,600 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PROCAPS GROUP SA finden Sie auf Wallstreet Online.
